In the artificial tear and loteprednol groups , although no significant improvement in any sign or symptom was noted in patients with low baseline SNFL ( < 16.84 mm/mm ( 2 ) ) , subjects with near-normal baseline SNFL ( 16.84 mm/mm ( 2 ) ) showed significant improvement in both symptoms and CFS score ( all P < 0.05 ) .